enVVeno Medical Corporation (NASDAQ: NVNO)
$3.3900
+0.0900 ( +2.73% ) 44.6K
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Market Data
Open
$3.3900
Previous close
$3.3000
Volume
44.6K
Market cap
$58.92M
Day range
$3.2950 - $3.4300
52 week range
$3.0120 - $6.9700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 7 | Nov 19, 2024 |
10-q | Quarterly Reports | 44 | Oct 31, 2024 |
8-k | 8K-related | 18 | Sep 30, 2024 |
10-q | Quarterly Reports | 42 | Jul 31, 2024 |
10-q | Quarterly Reports | 46 | May 08, 2024 |
8-k | 8K-related | 15 | Apr 24, 2024 |
4 | Insider transactions | 1 | Mar 15, 2024 |
8-k | 8K-related | 16 | Mar 06, 2024 |
10-k | Annual reports | 71 | Feb 29, 2024 |
4 | Insider transactions | 1 | Dec 07, 2023 |